Biomarker validation by targeted mass spectrometry

被引：0
|
作者：
Martin McIntosh
Matthew Fitzgibbon
机构：
[1] Martin McIntosh and Matthew Fitzgibbon are in the Computational Biology and Molecular Diagnostics Programs at the Fred Hutchinson Cancer Research Center,
[2] Seattle,undefined
[3] Washington,undefined
[4] USA.,undefined
来源：
Nature Biotechnology | 2009年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A multilaboratory study demonstrates the potential for establishing quantitative targeted proteomic assays for moderately to highly abundant plasma proteins.
引用
收藏
页码：622 / 623
页数：1
相关论文
共 50 条
  • [41] Mass spectrometry in targeted and differential proteomics
    Deterding, L. J.
    Bunger, M. K.
    Archer, T. K.
    Merrick, B. A.
    Bruno, M. E.
    Madenspacher, J. E.
    Dubin, J. R.
    Tomer, K. B.
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S124 - S124
  • [42] Targeted Quantitation of Proteins by Mass Spectrometry
    Liebler, Daniel C.
    Zimmerman, Lisa J.
    BIOCHEMISTRY, 2013, 52 (22) : 3797 - 3806
  • [43] Development of Multiplexed Assays for Oral Cancer Biomarker Verification by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry
    Hsiao, Yung-Chin
    Chi, Lang-Ming
    Chien, Kun-Yi
    Chen, Yi-Ting
    Chang, Yu-Sun
    Yu, Jau-Song
    MOLECULAR & CELLULAR PROTEOMICS, 2014, 13 (08) : S38 - S38
  • [44] Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
    Lu, Ming
    Faull, Kym F.
    Whitelegge, Julian P.
    He, Jianbo
    Shen, Dejun
    Saxton, Romaine E.
    Chang, Helena R.
    BIOMARKER INSIGHTS, 2007, 2 : 347 - 360
  • [45] The role of mass spectrometry in biomarker discovery and measurement
    Ackermann, Bradley L.
    Hale, John E.
    Duffin, Kevin L.
    CURRENT DRUG METABOLISM, 2006, 7 (05) : 525 - 539
  • [46] A Selected Reaction Monitoring Mass Spectrometry Protocol for Validation of Proteomic Biomarker Candidates in Studies of Psychiatric Disorders
    Reis-de-Oliveira, Guilherme
    Garcia, Sheila
    Guest, Paul C.
    Cassoli, Juliana S.
    Martins-de-Souza, Daniel
    PROTEOMIC METHODS IN NEUROPSYCHIATRIC RESEARCH, 2017, 974 : 213 - 218
  • [47] Label-Free Mass Spectrometry-Based Proteomics for Biomarker Discovery and Validation in Tissues and Biofluids
    Jimenez, C. R.
    Fijneman, R. J. A.
    Wit, M.
    Bosch, L.
    Piersma, S. R.
    Pham, T. V.
    Carvalho, B.
    Mongera, S.
    Verheul, H. M. W.
    Meijer, G. A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S34 - S34
  • [48] Biomarker discovery for kidney diseases by mass spectrometry
    Niwa, Toshimitsu
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2008, 870 (02): : 148 - 153
  • [49] ELISA validation and correlation to mass spectrometry
    Kouba, Kristen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [50] Mass Spectrometry in Biomarker Applications: From Untargeted Discovery to Targeted Verification, and Implications for Platform Convergence and Clinical Application
    Smith, Richard D.
    CLINICAL CHEMISTRY, 2012, 58 (03) : 528 - 530
12345